Jiao L - Search Results

1

Metabolomic evaluation of the response to endocrine therapy in patients with prostate cancer.

Huang G, Liu X, Jiao L, Xu C, Zhang Z, Wang L, Li Y, Yang C, Zhang W, Sun Y. Huang G, et al. Among authors: jiao l. Eur J Pharmacol. 2014 Apr 15;729:132-7. doi: 10.1016/j.ejphar.2014.01.048. Epub 2014 Feb 18. Eur J Pharmacol. 2014. PMID: 24556387

2

[Expressions of the androgen receptor in normal prostate, benign prostatic hyperplasia and prostate cancer].

Zeng R, Liu ZY, Sun YH, Xu CL, Gao X, Jiao L. Zeng R, et al. Among authors: jiao l. Zhonghua Nan Ke Xue. 2010 Nov;16(11):967-72. Zhonghua Nan Ke Xue. 2010. PMID: 21218636 Chinese.

3

Neural protein gamma-synuclein interacting with androgen receptor promotes human prostate cancer progression.

Chen J, Jiao L, Xu C, Yu Y, Zhang Z, Chang Z, Deng Z, Sun Y. Chen J, et al. Among authors: jiao l. BMC Cancer. 2012 Dec 11;12:593. doi: 10.1186/1471-2407-12-593. BMC Cancer. 2012. PMID: 23231703 Free PMC article.

4

The prostate cancer-up-regulated Myc-associated zinc-finger protein (MAZ) modulates proliferation and metastasis through reciprocal regulation of androgen receptor.

Jiao L, Li Y, Shen D, Xu C, Wang L, Huang G, Chen L, Yang Y, Yang C, Yu Y, Sun Y. Jiao L, et al. Med Oncol. 2013;30(2):570. doi: 10.1007/s12032-013-0570-3. Epub 2013 Apr 23. Med Oncol. 2013. PMID: 23609189

5

Dishevelled-2 silencing reduces androgen-dependent prostate tumor cell proliferation and migration and expression of Wnt-3a and matrix metalloproteinases.

Yang Y, Jiao L, Hou J, Xu C, Wang L, Yu Y, Li Y, Yang C, Wang X, Sun Y. Yang Y, et al. Among authors: jiao l. Mol Biol Rep. 2013 Jul;40(7):4241-50. doi: 10.1007/s11033-013-2506-6. Epub 2013 May 8. Mol Biol Rep. 2013. PMID: 23652996

6

miR-663 induces castration-resistant prostate cancer transformation and predicts clinical recurrence.

Jiao L, Deng Z, Xu C, Yu Y, Li Y, Yang C, Chen J, Liu Z, Huang G, Li LC, Sun Y. Jiao L, et al. J Cell Physiol. 2014 Jul;229(7):834-44. doi: 10.1002/jcp.24510. J Cell Physiol. 2014. PMID: 24243035

7

HOXA1 enhances the cell proliferation, invasion and metastasis of prostate cancer cells.

Wang H, Liu G, Shen D, Ye H, Huang J, Jiao L, Sun Y. Wang H, et al. Among authors: jiao l. Oncol Rep. 2015 Sep;34(3):1203-10. doi: 10.3892/or.2015.4085. Epub 2015 Jun 26. Oncol Rep. 2015. PMID: 26135141

8

miRNA-100 inhibits human bladder urothelial carcinogenesis by directly targeting mTOR.

Xu C, Zeng Q, Xu W, Jiao L, Chen Y, Zhang Z, Wu C, Jin T, Pan A, Wei R, Yang B, Sun Y. Xu C, et al. Among authors: jiao l. Mol Cancer Ther. 2013 Feb;12(2):207-19. doi: 10.1158/1535-7163.MCT-12-0273. Epub 2012 Dec 27. Mol Cancer Ther. 2013. PMID: 23270926

9

PPM1D as a novel biomarker for prostate cancer after radical prostatectomy.

Jiao L, Shen D, Liu G, Jia J, Geng J, Wang H, Sun Y. Jiao L, et al. Anticancer Res. 2014 Jun;34(6):2919-25. Anticancer Res. 2014. PMID: 24922655

10

Circulating MicroRNA as Potential Source for Neurodegenerative Diseases Biomarkers.

Zi Y, Yin Z, Xiao W, Liu X, Gao Z, Jiao L, Deng L. Zi Y, et al. Among authors: jiao l. Mol Neurobiol. 2015 Dec;52(3):1494-1503. doi: 10.1007/s12035-014-8944-x. Epub 2014 Nov 4. Mol Neurobiol. 2015. PMID: 25367880 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,650 results

Search Page

Filters